Limit treatment to the min period required to avoid emergence of resistant bacteria. Efficacy in MRSA has not been proven. Should be used in pregnancy only if expected therapeutic benefits outweigh possible risks. 1.5% w/v: Take at least 5-min intervals when using >1 ophth drug. Safety in low birth wt infants, neonates, infants or childn has not been established.
Sign Out
